[Laparoscopic hysterectomy after GnRh analogue therapy]

Area of Science:

• Reproductive Endocrinology
• Gynecologic Surgery
• Medical Therapeutics

Context:

• Uterine fibroids (leiomyomas) and metrorrhagia pose significant clinical challenges.
• Laparoscopic hysterectomy is a common surgical approach for these conditions.
• Preoperative management strategies are crucial for optimizing surgical outcomes.

Purpose:

• To evaluate the efficacy of gonadotropin-releasing hormone (GnRH) analogue treatment prior to laparoscopic hysterectomy.
• To assess the impact of this treatment on uterine volume and hemoglobin levels in patients with fibroids and metrorrhagia.

Summary:

• A prospective study involved 40 women with an average uterine volume of 510 cm³.
• Patients received a single dose of triptorelin 11.25 mg. Uterine volume was reassessed after 3 months.
• GnRH analogue treatment resulted in a significant 4% uterine volume reduction in 85% of patients, alongside a 2-3 g increase in hemoglobin.

Impact:

• Preoperative GnRH analogue therapy offers a valuable option for managing uterine leiomyomas and associated metrorrhagia.
• This approach may lead to improved surgical conditions and patient recovery.
• The study highlights the potential benefits of medical management in conjunction with surgical intervention.